Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
ROIV
ROIV News & Events
-
Add to Watchlist
Trade ROIV Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
ROIV News
Roivant Sciences Plans Three Drug Launches Over Next Three Years
21h ago
NASDAQ.COM
Arbutus and Moderna Reach $2.25 Billion Settlement
13h ago
stocktwits
Roivant Sciences: A Rising Star in Biotech with Massive Potential
21h ago
Fool
Executive Stock Sale Announcement
Jun 30 2026
Yahoo Finance
Roivant Sciences Q4 2025 Earnings Call Insights Highlight Key Developments
May 20 2026
seekingalpha
Roivant (ROIV) Q4 2025 Earnings Transcript
May 20 2026
NASDAQ.COM
Roivant Sciences Releases Preliminary Data from 1402 Study
May 20 2026
Yahoo Finance
Roivant Sciences Reports $355.7M Net Income, Shares Surge
May 20 2026
stocktwits
Show More News
ROIV Events
No data
ROIV Monitor News
Roivant Sciences Plans Three Drug Launches Over Next Three Years
Jul 07 2026
Roivant Sciences hits 52-week high amid market gains
Jun 24 2026
Roivant Sciences Q4 Earnings Beat Expectations
May 20 2026
Brepocitinib Shows Significant Benefits in Dermatomyositis Trial
Mar 31 2026
Roivant Sciences benefits from Moderna's patent settlement
Mar 04 2026
Roivant Sciences Stock Soars on Positive Phase 2 Results for Brepocitinib
Feb 09 2026
Roivant Sciences Reports Positive Phase 2 Results for Brepocitinib
Feb 06 2026
Roivant Sciences reaches 5-day high amid market fluctuations
Jan 13 2026
Show More Monitor News
ROIV Earnings Analysis
Roivant Sciences Earnings & Drug Discoveries Update- Intellectia AI™
7 months ago
Roivant Sciences Shows Resilience with Strategic Advancements - Intellectia AI™
1 years ago
Roivant Reports Second Quarter Financial Results for 2024
1 years ago
People Also Watch
